A traditionally troublesome month is turning out to be anything but for the stock market…so far.
The Food and Drug Administration should authorize a second ‘booster’ dose of Johnson & Johnson’s COVID-19 vaccine for adults who were initially imm…
Get news sent directly to your inbox
Get breaking news and incisive analysis sent to your inbox. Choose from a number of free newsletter options at MarketWatch, including Need to Know, which provides a guide to the trading day.